EQT Private Equity, a global investment organization founded in 1994, executed an additional investment and renewed long-term commitment in IVC Evidensia. As part of its long-term commitment to IVC, EQT Private Equity made a substantial investment through its EQT IX fund. Silver Lake, a leading global technology investment firm, made a new substantial minority investment in IVC. Nestlé, which joined EQT Private Equity in 2019 as a minority investor and strategic partner, also increased its minority stake in IVC.
Headquartered in Bristol, UK, IVC is a leading veterinary services provider with a network of more than 1,500 clinics and hospitals and approximately 22,000 employees across Europe. Founded in 2011, IVC operates a decentralized model promoting innovation and clinical freedom balanced with integrated support functions such as procurement, veterinary advisors and clinical boards.
The Kirkland team advising EQT was led by transactional partners Roger Johnson, David Holdsworth (Picture), Tom Bartram, Andreas Philipson and associate Irfan Ahmed.
Latham & Watkins advised Silver Lake Partners with London corporate partners David Walker and Farah O’Brien, associates Suneel Basson-Bhatoa, Antonina Semyachkova, Hannah Berdal, and Angharad Simon.
Involved fees earner: Irfan Ahmed – Kirkland & Ellis; Tom Bartram – Kirkland & Ellis; David Holdsworth – Kirkland & Ellis; Roger Johnson – Kirkland & Ellis; Andreas Philipson – Kirkland & Ellis; Suneel Basson-Bhatoa – Latham & Watkins; Hannah Berdal – Latham & Watkins; Farah O’Brien – Latham & Watkins; Antonina Semyachkova – Latham & Watkins; Angharad Simon – Latham & Watkins; David Walker – Latham & Watkins;